If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,592.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.125%)
Market Cap: £1.62b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Directorate Change

27 Apr 2022 07:00

RNS Number : 4419J
Greggs PLC
27 April 2022
 

 

 

 

GREGGS plc

 

Board Changes

The Board of Greggs plc announces that it has appointed Lynne Weedall as an independent non-executive director, with effect from 17 May 2022. Lynne will join the Board immediately following the close of the Annual General Meeting currently scheduled on that date.

Lynne is an experienced People and Business Transformation executive, having held senior positions most recently at Selfridges, and before that at Carphone Warehouse. Throughout her executive career Lynne has been involved in and led transformational projects in several of the companies she has worked for, which have also included Whitbread, and BUPA.

Lynne is currently the senior independent non-executive director and Remuneration Committee Chair at Dr. Martens plc, and at Stagecoach plc, and on 3 May 2022 is due to join the Board of Softcat plc as non-executive director and Chair of the Remuneration Committee. Lynne is also a non-executive director and Nominations Committee chair at Treatt plc. Lynne was previously a non-executive director and Remuneration Committee Chair of Greene King plc from 2012 until 2019 and William Hill plc from 2019 until April 2021.

The Board intends that Lynne will be appointed as Chair of the Remuneration Committee when Helena Ganczakowski steps down from the Board in 2023.

Ian Durant, Chair of Greggs, said "We are delighted that such an experienced non-executive director has accepted our invitation to join the Board. Lynne brings with her extensive experience of HR & transformational change, and will add significant value to our Board during this transitional phase and beyond".

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Lynne Weedall.

ENDS

ENQUIRIES:

 

 

Greggs plc

Hudson Sandler

Roger Whiteside, Chief Executive

Richard Hutton, Finance Director

Hattie Dreyfus / Nick Moore / Sophie Miles

Tel: 0191 281 7721

 

Tel: 020 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPURWCUPPGMQ
Date   Source Headline
11th Mar 20151:01 pmRNSDirector/PDMR Shareholding
11th Mar 201512:56 pmRNSDirector/PDMR Shareholding
11th Mar 201512:52 pmRNSDirector/PDMR Shareholding
5th Mar 201510:50 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSPreliminary Results
12th Feb 20152:27 pmRNSNotice of Results
13th Jan 20157:00 amRNSTrading Update
6th Jan 20157:00 amRNSNotice of Trading Update
15th Dec 20147:00 amRNSTrading Update
8th Dec 20147:00 amRNSBlocklisting Interim Review
8th Dec 20147:00 amRNSBlocklisting Interim Review
15th Sep 20147:00 amRNSInterim Management Statement
14th Aug 20143:24 pmRNSDirector/PDMR Shareholding
30th Jul 20147:00 amRNSInterim Results
8th Jul 201411:13 amRNSHolding(s) in Company
1st Jul 20147:00 amRNSHalf Year Trading Statement
17th Jun 20143:16 pmRNSHolding(s) in Company
12th Jun 20149:38 amRNSNotice of Interim results
9th Jun 20144:38 pmRNSDirector Declaration
6th Jun 201411:43 amRNSBlocklisting Interim Review
6th Jun 201411:43 amRNSBlocklisting Interim Review
3rd Jun 20144:41 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:40 pmRNSDirector/PDMR Shareholding
6th May 20143:53 pmRNSRe-appointment of Auditors
2nd May 20142:19 pmRNSResult of AGM
1st May 20143:12 pmRNSDirectorate Change
30th Apr 20147:00 amRNSInterim Management Statement
7th Apr 20149:30 amRNSNotice of IMS
31st Mar 20143:14 pmRNSDirector/PDMR Shareholding
28th Mar 201411:20 amRNSAnnual Financial Report
18th Mar 20144:17 pmRNSDirector/PDMR Shareholding
18th Mar 20144:17 pmRNSDirector/PDMR Shareholding
18th Mar 20144:16 pmRNSDirector/PDMR Shareholding
10th Mar 20147:00 amRNSDirectorate Change
26th Feb 20147:00 amRNSPreliminary Results
20th Feb 20145:11 pmRNSHolding(s) in Company
24th Jan 20142:04 pmRNSDirector Declaration
20th Jan 20149:04 amRNSNotice of Results
9th Jan 20147:00 amRNSTrading Update
20th Dec 20132:23 pmRNSNotice of Trading Update
6th Dec 20137:12 amRNSBlocklisting Interim Review
6th Dec 20137:12 amRNSBlocklisting Interim Review
28th Nov 20138:45 amRNSDirectorate Change
9th Oct 20137:00 amRNSInterim Management Statement
24th Sep 20132:00 pmRNSNotice of IMS
23rd Sep 20138:02 amRNSHolding(s) in Company
23rd Aug 20138:14 amRNSDirector Declaration
22nd Aug 20139:00 amRNSHolding(s) in Company
6th Aug 20137:00 amRNSInterim Results
31st Jul 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.